ORTX Orchard Therapeutics plc-ADR
0.5661 -0.0337 (-5.62%)
Delayed Prices By NASDAQ, in USD Market Closed
ORTX Orchard Therapeutics plc-ADR
Market Cap
71.65M
Day’s Range
52W Range
Volume (3M)
928.69K
Price-Earnings Ratio
-
Revenue
16.03M
Orchard Therapeutics plc-ADR Latest News
View All


About Orchard Therapeutics plc-ADR
Operating internationally, Orchard Therapeutics is a biopharmaceutical company. It works to develop gene therapies to treat serious and life-threatening rare diseases. Founded in 2015, the company has headquarters in London, UK. Orchard Therapeutics trades on the NASDAQ GS stock market with the ticker of ORTX. Find the best time to invest in ORTX stock when you add it to your eToro watchlist.
Show More259
Employees
London, Greater London, US
HQ
2018
Founded
Bobby Gaspar, MD, PhD
CEO
People Also Bought
- CLLS Cellectis SA-ADR -2.22%
- SFT Shift Technologies Inc Class A 1.94%
- OCUL Ocular Therapeutix Inc -0.26%
- RIGL Rigel Pharmaceuticals Inc -3.74%
MIGI Mawson Infrastructure Group Inc. 3.22%
IMAB I-Mab-ADR 6.08%
NSTG NanoString Technologies Inc. 3.75%
- BHG Bright Health Group Inc. 13.95%